Suspension of trading
ICAD Share Price
Stocks
ICAD
US44934S2068
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
01:30:00 17/07/2025 am IST
|
5-day change | 1st Jan Change | ||
| 3.870 USD | +3.75% |
|
-.--% | - |
| 21/25/21 | ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index | CI |
| 18/25/18 | ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index | CI |
| Market Cap | 11Cr 9.29Cr 8.76Cr 7.99Cr 15Cr 1.01TCr 15Cr 105.07Cr 41Cr 515.87Cr 40Cr 39Cr 1.68TCr | P/E 2023 |
-9.35x | P/E 2024 | -8.59x |
|---|---|---|---|---|---|
| Enterprise Value | 8.87Cr 7.81Cr 7.36Cr 6.71Cr 13Cr 851.92Cr 13Cr 88Cr 34Cr 433.58Cr 33Cr 33Cr 1.41TCr | EV / Sales 2023 |
1.47x | EV / Sales 2024 | 1.6x |
| Free-Float |
99.32% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +3.75% |
| 3 years | 1.18 |  | 4.02 |
| 5 years | 1.05 | | 12.6 |
| 10 years | 1.05 | | 21.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dana Brown
CEO | Chief Executive Officer | 61 | 10/03/2023 |
Mark Stolper
DFI | Director of Finance/CFO | 54 | 17/07/2025 |
Dave Katz
SEC | Corporate Secretary | - | 17/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/07/25 | Issuer sale | Director | 15,53,657 | 5.8540% | ||
| 17/07/25 | Issuer sale | Chief Financial Officer | 1,58,488 | 0.5972% | ||
| 17/07/25 | Issuer sale | Chief Technology Officer | 3,51,145 | 1.3231% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.75% | -.--% | -.--% | +104.76% | 11Cr | |
| +1.97% | +3.05% | +44.96% | +34.16% | 25TCr | |
| +1.00% | +5.30% | +20.36% | -11.22% | 16TCr | |
| +0.31% | +4.17% | -10.02% | +36.24% | 14TCr | |
| +0.13% | +2.59% | -54.44% | -16.95% | 6.47TCr | |
| -1.26% | -2.86% | +14.83% | +23.42% | 5TCr | |
| +0.03% | -3.00% | -20.96% | -21.61% | 4.72TCr | |
| +4.55% | +10.55% | +38.96% | +54.40% | 4.66TCr | |
| +2.31% | +0.13% | +47.04% | +58.81% | 4.13TCr | |
| +7.25% | +11.71% | +190.12% | +108.43% | 3.86TCr | |
| Average | +2.00% | +3.21% | +27.08% | +37.04% | 8.31TCr | |
| Weighted average by Cap. | +1.27% | +3.64% | +24.24% | +24.03% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 1.73Cr 1.52Cr 1.44Cr 1.31Cr 2.45Cr 166.24Cr 2.47Cr 17Cr 6.68Cr 85Cr 6.5Cr 6.36Cr 275.32Cr | 1.96Cr 1.72Cr 1.63Cr 1.48Cr 2.77Cr 188.22Cr 2.8Cr 20Cr 7.56Cr 96Cr 7.36Cr 7.2Cr 311.73Cr |
| Net income | -48.47L -42.63L -40.19L -36.67L -68.57L -47Cr -69.11L -4.82Cr -1.87Cr -24Cr -1.82Cr -1.78Cr -77Cr | -56.16L -49.4L -46.57L -42.49L -79.45L -54Cr -80.07L -5.59Cr -2.17Cr -27Cr -2.11Cr -2.06Cr -89Cr |
| Net Debt | -2.12Cr -1.87Cr -1.76Cr -1.6Cr -3Cr -203.59Cr -3.02Cr -21Cr -8.18Cr -103.62Cr -7.96Cr -7.79Cr -337.18Cr | -1.68Cr -1.48Cr -1.4Cr -1.27Cr -2.38Cr -161.69Cr -2.4Cr -17Cr -6.49Cr -82Cr -6.32Cr -6.19Cr -267.78Cr |
Employees
66
- Stock Market
- Stocks
- ICAD Stock
Select your edition
All financial news and data tailored to specific country editions
